ValiRx plc (LON:VAL – Get Rating)’s stock price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 12.97 ($0.16) and traded as high as GBX 17.34 ($0.21). ValiRx shares last traded at GBX 17.25 ($0.21), with a volume of 1,388,393 shares traded.
ValiRx Stock Performance
The firm has a fifty day simple moving average of GBX 12.97 and a 200-day simple moving average of GBX 19.89. The stock has a market cap of £15.56 million and a price-to-earnings ratio of -7.50. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 1.77.
ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a small molecule that has completed Phase I/II trials for the treatment of prostate cancer and other hormone associated solid tumours comprising breast and ovarian cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of non-small cell lung cancer.
- What Steelcase’s Earnings Say About the Return to the Office?
- The Institutions Hold On To Darden Restaurants International
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Is The Golden Age Of Homebuilding Already Over?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.